Please login to the form below

MDR

This page shows the latest MDR news and features for those working in and with pharma, biotech and healthcare.

Pharma must do more on antibiotic resistance, Davos meeting hears

In particular, more needs to be done to bring forward new drugs for multidrug resistant (MDR) pathogens or ‘superbugs’ - there are currently 28 novel drugs for high-priority pathogens in phase

Latest news

Pfizer launches antibiotic resistance surveillance website

Meanwhile, Pfizer’s new antibiotic for multidrug resistant (MDR) infections, Zavicefta, was launched in its first European markets earlier this year after the pharma firm paid its developer AstraZeneca $1.58bn
Pfizer launches new antibiotic Zavicefta in UK and Germany

Pfizer launches new antibiotic Zavicefta in UK and Germany. Biopharmaceutical company Pfizer releases MDR antibiotic. ... Pfizer's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been launched in the UK and Germany, its first EU
AZ slims down again with sale of antibiotics to Pfizer

ATM-AVI is in trials for life-threatening Gram-negative bacterial infections caused by multi-drug resistant (MDR) strains, while CXL has activity against MDR Gram-positive and Gram-negative pathogens.
AZ gets EU green light for new antibiotic Zavicefta

AstraZeneca's new antibiotic for multidrug resistant (MDR) infections - Zavicefta - has been approved for marketing in the EU. ... In 2014 Professor Sally Davies, the UK Chief Medical Officer, warned that countries are facing an 'apocalypse' if measures
Merck starts pivotal trials of new antibiotic combination

Beta-lactamase inhibitor relebactam is a welcome addition to the late-stage antibiotics pipeline, which remains fairly sparse despite high levels of concern worldwide about multidrug resistant (MDR) infections. ... An independent UK review estimated in

More from news
Approximately 4 fully matching, plus 30 partially matching documents found.

Latest Intelligence

Medical device regulation - a risk-based approach to compliance

Simply put, complying with MDR is another stressor for medtechs at an already challenging time, potentially affecting both top- and bottom-line growth. ... It's difficult to estimate just how great the costs associated with MDR implementation will
The impending threat of antibiotic resistance

Antibiotic Research UK is the BIA's charity of 2015, but what does it intend to do?

More from intelligence
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...: EXCELLENT DAY RATES AVAILABLE

Senior Account Manager – Med Comms – Kent: Salary TBC

Account Manager, Healthcare PR: £40, 000 – £42, 000 great benefits and bonuses

Project Manager, Medical Communications, Oxford: Excellent Salary

HOME BASED Senior Account Executive / Account Manager - Medical ...: Salary TBC

Senior Medical Writer: Great salary and bebefits

Principal Medical Writer, Medical Communications, Relocate to Ca...: Excellent Salary

Editor > Senior Editor – Medical Education – London: Very competitive with excellent benefits

Medical Writer - (London, Brighton or Copenhagen): Competitive

Project Manager, Medical Communications, London: Excellent Salary

Digital Senior Account Director – Healthcare Advertising – Londo...: Salary TBC

Senior Programme Executive: Salary TBC

Editorial Director – Medical Education – Oxford: Negotiable

Engagement Strategist, Healthcare Brand Communications, London, ...: Circa £60K

Medical Writer, e-learning/ training, London: Excellent Salary

Account Manager – Med Comms – London: Salary TBC

Scientific Director: Great salary and bebefits

Senior / Principal Regulatory Writer – Home Working - UK or US: HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS

Senior Medical Writer, Medical Communications, Relocate to Cardi...: Excellent Salary

Group Account Director, Healthcare Brand Communications, London: Excellent Package

Senior Account Manager or AD - Medical Communications: Salary TBC

Editorial Team Leader or Scientific Director: £50, 000 - £55, 000 benefits

Science writer, Healthcare Brand Communications, London, £45-50K...: £45-50K

Senior Account Director, Healthcare Brand Communications, London: Excellent Package

Senior Account Manager / Account Director: Great salary and bebefits

Subscribe to our email news alerts

No results were found

PMHub

Add my company

Aptus Health

Aptus Health is dedicated to advancing health engagement. The company offers end-to-end digital health engagement solutions spanning all areas of...

Latest intelligence

The threat of antimicrobial resistance: Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies: Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation: HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...